Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: results from LUMINA (LXXIX), a multiethnic, multicentre US cohort.

Ugarte-Gil MF, Pons-Estel GJ, Vila LM, McGwin G, Alarcón GS.

RMD Open. 2019 May 23;5(1):e000955. doi: 10.1136/rmdopen-2019-000955. eCollection 2019.

2.

Factors Associated With Disease Damage in Puerto Ricans With Primary Sjögren Syndrome.

Jordán-González P, Gago-Piñero R, Vázquez-Sanabria I, Pérez-Ríos N, Vilá LM.

J Clin Rheumatol. 2019 Mar 12. doi: 10.1097/RHU.0000000000001023. [Epub ahead of print]

PMID:
30870254
3.

Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort.

Alarcón GS, Ugarte-Gil MF, Pons-Estel G, Vilá LM, Reveille JD, McGwin G Jr.

Lupus. 2019 Mar;28(3):423-426. doi: 10.1177/0961203319826693. Epub 2019 Jan 24.

PMID:
30678605
4.

Association of soluble TREM-like transcript-1 with clinical features and patient reported outcomes in systemic lupus erythematosus.

Vázquez-Otero I, Rodríguez-Navedo Y, Vilá-Rivera K, Nieves-Plaza M, Morales-Ortiz J, Washington AV, Vilá LM.

Eur J Rheumatol. 2018 Dec;5(4):244-248. doi: 10.5152/eurjrheum.2018.18074. Epub 2018 Oct 10.

5.

A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus.

Patel ZH, Lu X, Miller D, Forney CR, Lee J, Lynch A, Schroeder C, Parks L, Magnusen AF, Chen X, Pujato M, Maddox A, Zoller EE, Namjou B, Brunner HI, Henrickson M, Huggins JL, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath SK, Stevens AM, Freedman BI, Pons-Estel BA, Tsao BP, Jacob CO, Kamen DL, Brown EE, Gilkeson GS, Alarcón GS, Martin J, Reveille JD, Anaya JM, James JA, Sivils KL, Criswell LA, Vilá LM, Petri M, Scofield RH, Kimberly RP, Edberg JC, Ramsey-Goldman R, Bang SY, Lee HS, Bae SC, Boackle SA, Cunninghame Graham D, Vyse TJ, Merrill JT, Niewold TB, Ainsworth HC, Silverman ED, Weisman MH, Wallace DJ, Raj P, Guthridge JM, Gaffney PM, Kelly JA, Alarcón-Riquelme ME, Langefeld CD, Wakeland EK, Kaufman KM, Weirauch MT, Harley JB, Kottyan LC.

Hum Mol Genet. 2018 Jul 1;27(13):2392-2404. doi: 10.1093/hmg/ddy140.

6.

Clinical correlates and outcomes in a group of Puerto Ricans with systemic lupus erythematosus hospitalized due to severe infections.

Jordán-González P, Shum LM, González-Sepúlveda L, Vilá LM.

SAGE Open Med. 2018 May 21;6:2050312118778385. doi: 10.1177/2050312118778385. eCollection 2018.

7.

Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus.

Jolly M, Sequeira W, Block JA, Toloza S, Bertoli A, Blazevic I, Vila LM, Moldovan I, Torralba KD, Mazzoni D, Cicognani E, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Mok CC, Weisman M, Clarke AE, Wallace D, Alarcón G.

Arthritis Care Res (Hoboken). 2018 Apr 25. doi: 10.1002/acr.23588. [Epub ahead of print]

8.

Efficacy of Cyclosporine in the Induction and Maintenance of Remission in a Systemic Lupus Erythematosus Patient Presenting with Macrophage-Activating Syndrome.

Cruz-Pérez F, Vilá S, Ríos G, Vilá LM.

Case Rep Rheumatol. 2018 Jan 15;2018:1961585. doi: 10.1155/2018/1961585. eCollection 2018.

9.

Long-Term Outcomes in Puerto Ricans with Rheumatoid Arthritis (RA) Receiving Early Treatment with Disease-Modifying Anti-Rheumatic Drugs using the American College of Rheumatology Definition of Early RA.

Varela-Rosario N, Arroyo-Ávila M, Fred-Jiménez RM, Díaz-Correa LM, Pérez-Ríos N, Rodríguez N, Ríos G, Vilá LM.

Open Rheumatol J. 2017 Dec 27;11:136-144. doi: 10.2174/1874312901711010136. eCollection 2017.

10.

Severe systemic inflammatory response syndrome immediately after spinal surgery in a patient with axial gout.

Gago R, Vilá S, Vélez-Rivera J, Vilá LM.

BMJ Case Rep. 2018 Jan 24;2018. pii: bcr-2017-222474. doi: 10.1136/bcr-2017-222474.

PMID:
29367221
11.

Efficacy of Rituximab in a Systemic Lupus Erythematosus Patient Presenting with Diffuse Alveolar Hemorrhage.

Montes-Rivera G, Ríos G, Vilá LM.

Case Rep Rheumatol. 2017;2017:6031053. doi: 10.1155/2017/6031053. Epub 2017 Nov 15.

12.

Transancestral mapping and genetic load in systemic lupus erythematosus.

Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ.

Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.

13.

Right upper quadrant abdominal pain as the initial presentation of polyarteritis nodosa.

Gago R, Shum LM, Vilá LM.

BMJ Case Rep. 2017 Feb 22;2017. pii: bcr2016218019. doi: 10.1136/bcr-2016-218019.

14.

Clinical Manifestations Associated with Peripheral Joint Involvement in Patients with Acute Chikungunya Virus Infection.

Arroyo-Ávila M, Cabán A, García-Rivera EJ, Irizarry-Pérez M, Torres H, Gorbea H, Vilá LM.

Am J Trop Med Hyg. 2017 Apr;96(4):916-921. doi: 10.4269/ajtmh.16-0890. Epub 2017 Jan 30.

15.

A unique antiphospholipid assay recognizing phospholipid mixture compared with criteria antiphospholipid immunoassays in lupus patients.

Zuo Y, Willis R, Papalardo E, Petri M, Harris EN, Schleh A, DeCeulaer K, Smikle M, Vilá LM, Reveille JD, Alarcón GS, Gonzalez EB.

Lupus. 2017 May;26(6):606-615. doi: 10.1177/0961203316671812. Epub 2016 Oct 16.

PMID:
27753626
16.

Patient-reported outcome measures in a population of medically indigent patients with systemic lupus erythematosus in Puerto Rico.

Rodríguez-Rivera DV, Rodríguez-Navedo Y, Nieves-Plaza M, Vilá LM.

SAGE Open Med. 2016 Sep 23;4:2050312116670927. eCollection 2016.

17.

Olecranon Bursitis Caused by Candida parapsilosis in a Patient with Rheumatoid Arthritis.

Gamarra-Hilburn CF, Rios G, Vilá LM.

Case Rep Rheumatol. 2016;2016:2019250. doi: 10.1155/2016/2019250. Epub 2016 Aug 9.

18.

Factors associated with disease expression patterns in systemic lupus erythematosus patients: results from LUMINA (LXXVII), a multiethnic US cohort.

Ugarte-Gil MF, Pimentel-Quiroz VR, Vilá LM, Reveille JD, McGwin G Jr, Alarcón GS.

Lupus. 2017 May;26(6):650-655. doi: 10.1177/0961203316665710. Epub 2016 Aug 24.

PMID:
27558795
19.

Sustained Improvement of Fibromyalgia Syndrome After Electroconvulsive Therapy for Intractable Depression.

Vázquez-Sanabria IL, Vilá LM.

J Clin Rheumatol. 2016 Aug;22(5):289-90. doi: 10.1097/RHU.0000000000000386. No abstract available.

PMID:
27464782
20.

Efficacy of immunosuppressive treatment in a systemic lupus erythematosus patient presenting with inclusion body myositis.

Varela-Rosario N, Pérez-Berenguer JL, Vilá LM.

BMJ Case Rep. 2016 Apr 5;2016. pii: bcr2016215035. doi: 10.1136/bcr-2016-215035.

21.

Clinical Manifestations Associated with Overweight/Obesity in Puerto Ricans with Fibromyalgia Syndrome.

Fred-Jiménez RM, Arroyo-Ávila M, Mayor ÁM, Ríos G, Vilá LM.

J Obes. 2016;2016:1379289. doi: 10.1155/2016/1379289. Epub 2016 Jan 18.

22.

Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production.

Deng Y, Zhao J, Sakurai D, Sestak AL, Osadchiy V, Langefeld CD, Kaufman KM, Kelly JA, James JA, Petri MA, Bae SC, Alarcón-Riquelme ME, Alarcón GS, Anaya JM, Criswell LA, Freedman BI, Kamen DL, Gilkeson GS, Jacob CO, Merrill JT, Gaffney PM, Sivils KM, Niewold TB, Ramsey-Goldman R, Reveille JD, Scofield RH, Stevens AM, Boackle SA, Vilá LM, Sohn II, Lee S, Chang DM, Song YW, Vyse TJ, Harley JB, Brown EE, Edberg JC, Kimberly RP, Cantor RM, Hahn BH, Grossman JM, Tsao BP.

Ann Rheum Dis. 2016 Nov;75(11):2007-2013. doi: 10.1136/annrheumdis-2015-208441. Epub 2016 Jan 18.

23.

Reply: To PMID 26710364.

Arroyo-Ávila M, Vilá LM.

P R Health Sci J. 2015 Dec;34(4):232. No abstract available.

PMID:
26710365
24.

Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus.

Zhao J, Wu H, Langefeld CD, Kaufman KM, Kelly JA, Bae SC; Marta E. Alarcón-Riquelme for the BIOLUPUS and GENLES networks, Alarcón GS, Anaya JM, Criswell LA, Freedman BI, Kamen DL, Gilkeson GS, Jacob CO, James JA, Merrill JT, Gaffney PM, Sivils KM, Niewold TB, Petri MA, Song ST, Jeong HJ, Ramsey-Goldman R, Reveille JD, Scofield RH, Stevens AM, Boackle SA, Vilá LM, Chang DM, Song YW, Vyse TJ, Harley JB, Brown EE, Edberg JC, Kimberly RP, Hahn BH, Grossman JM, Tsao BP, La Cava A.

Clin Immunol. 2015 Dec;161(2):157-62. doi: 10.1016/j.clim.2015.09.007. Epub 2015 Sep 16.

25.

Efficacy of intravenous immunoglobulins in a patient with systemic lupus erythematosus presenting with Stevens-Johnson syndrome.

Vázquez-Sanabria IL, Mercado-Seda R, Varela-Rosario N, Vilá LM.

BMJ Case Rep. 2015 Jul 22;2015. pii: bcr2015211157. doi: 10.1136/bcr-2015-211157. No abstract available.

26.

Rheumatic Manifestations in Patients with Chikungunya Infection.

Arroyo-Ávila M, Vilá LM.

P R Health Sci J. 2015 Jun;34(2):71-7. Review.

PMID:
26061056
27.

Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort.

Arroyo-Ávila M, Santiago-Casas Y, McGwin G Jr, Cantor RS, Petri M, Ramsey-Goldman R, Reveille JD, Kimberly RP, Alarcón GS, Vilá LM, Brown EE.

Clin Rheumatol. 2015 Jul;34(7):1217-23. doi: 10.1007/s10067-015-2941-y. Epub 2015 Apr 22.

28.

Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression.

Lu X, Zoller EE, Weirauch MT, Wu Z, Namjou B, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath SK, Stevens AM, Freedman BI, Tsao BP, Jacob CO, Kamen DL, Brown EE, Gilkeson GS, Alarcón GS, Reveille JD, Anaya JM, James JA, Sivils KL, Criswell LA, Vilá LM, Alarcón-Riquelme ME, Petri M, Scofield RH, Kimberly RP, Ramsey-Goldman R, Joo YB, Choi J, Bae SC, Boackle SA, Graham DC, Vyse TJ, Guthridge JM, Gaffney PM, Langefeld CD, Kelly JA, Greis KD, Kaufman KM, Harley JB, Kottyan LC.

Am J Hum Genet. 2015 May 7;96(5):731-9. doi: 10.1016/j.ajhg.2015.03.002. Epub 2015 Apr 9.

29.

Early-onset neutropenia induced by rituximab in a patient with lupus nephritis and hemolytic anemia.

Arroyo-Ávila M, Fred-Jiménez RM, Vilá LM.

Case Rep Rheumatol. 2015;2015:616787. doi: 10.1155/2015/616787. Epub 2015 Feb 12.

30.

Lupus risk variants in the PXK locus alter B-cell receptor internalization.

Vaughn SE, Foley C, Lu X, Patel ZH, Zoller EE, Magnusen AF, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath S, Stevens AM, Freedman BI, Tsao BP, Jacob CO, Kamen DL, Brown EE, Gilkeson GS, Alarcón GS, Reveille JD, Anaya JM, James JA, Moser KL, Criswell LA, Vilá LM, Alarcón-Riquelme ME, Petri M, Scofield RH, Kimberly RP, Ramsey-Goldman R, Binjoo Y, Choi J, Bae SC, Boackle SA, Vyse TJ, Guthridge JM, Namjou B, Gaffney PM, Langefeld CD, Kaufman KM, Kelly JA, Harley IT, Harley JB, Kottyan LC.

Front Genet. 2015 Jan 8;5:450. doi: 10.3389/fgene.2014.00450. eCollection 2014.

31.

Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.

Martins M, Williams AH, Comeau M, Marion M, Ziegler JT, Freedman BI, Merrill JT, Glenn SB, Kelly JA, Sivils KM, James JA, Guthridge JM, Alarcón-Riquelme ME, Bae SC, Kim JH, Kim D, Anaya JM, Boackle SA, Criswell LA, Kimberly RP, Alarcón GS, Brown EE, Vilá LM, Petri MA, Ramsey-Goldman R, Niewold TB, Tsao BP, Gilkeson GS, Kamen DL, Jacob CO, Stevens AM, Gaffney PM, Harley JB, Langefeld CD, Fesel C.

Genes Immun. 2015 Mar;16(2):142-50. doi: 10.1038/gene.2014.73. Epub 2015 Jan 8.

32.

Cardiac tamponade in a patient with mixed connective tissue disease.

Arroyo-Ávila M, Vilá LM.

J Clin Rheumatol. 2015 Jan;21(1):42-5. doi: 10.1097/RHU.0000000000000209. Review. No abstract available.

PMID:
25539437
33.

Limited systemic sclerosis initially presenting with mesenteric panniculitis.

Arroyo-Ávila M, Vilá LM.

BMJ Case Rep. 2014 Oct 17;2014. pii: bcr2014206961. doi: 10.1136/bcr-2014-206961.

34.

Granulomatosis with polyangiitis complicated with bronchopleural fistula.

Díaz-Correa LM, de León-Tellado N, Ríos G, Vilá LM.

BMJ Case Rep. 2014 Sep 23;2014. pii: bcr2014205145. doi: 10.1136/bcr-2014-205145. No abstract available.

35.

Factors associated with tender point count in Puerto Ricans with fibromyalgia syndrome.

Ríos G, Estrada M, Mayor AM, Vilá LM.

P R Health Sci J. 2014 Sep;33(3):112-6.

36.

The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share.

Kottyan LC, Zoller EE, Bene J, Lu X, Kelly JA, Rupert AM, Lessard CJ, Vaughn SE, Marion M, Weirauch MT, Namjou B, Adler A, Rasmussen A, Glenn S, Montgomery CG, Hirschfield GM, Xie G, Coltescu C, Amos C, Li H, Ice JA, Nath SK, Mariette X, Bowman S; UK Primary Sjögren's Syndrome Registry, Rischmueller M, Lester S, Brun JG, Gøransson LG, Harboe E, Omdal R, Cunninghame-Graham DS, Vyse T, Miceli-Richard C, Brennan MT, Lessard JA, Wahren-Herlenius M, Kvarnström M, Illei GG, Witte T, Jonsson R, Eriksson P, Nordmark G, Ng WF; UK Primary Sjögren's Syndrome Registry, Anaya JM, Rhodus NL, Segal BM, Merrill JT, James JA, Guthridge JM, Scofield RH, Alarcon-Riquelme M, Bae SC, Boackle SA, Criswell LA, Gilkeson G, Kamen DL, Jacob CO, Kimberly R, Brown E, Edberg J, Alarcón GS, Reveille JD, Vilá LM, Petri M, Ramsey-Goldman R, Freedman BI, Niewold T, Stevens AM, Tsao BP, Ying J, Mayes MD, Gorlova OY, Wakeland W, Radstake T, Martin E, Martin J, Siminovitch K, Moser Sivils KL, Gaffney PM, Langefeld CD, Harley JB, Kaufman KM.

Hum Mol Genet. 2015 Jan 15;24(2):582-96. doi: 10.1093/hmg/ddu455. Epub 2014 Sep 8.

37.

Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.

Zhao J, Giles BM, Taylor RL, Yette GA, Lough KM, Ng HL, Abraham LJ, Wu H, Kelly JA, Glenn SB, Adler AJ, Williams AH, Comeau ME, Ziegler JT, Marion M, Alarcón-Riquelme ME; BIOLUPUS and GENLES Networks, Alarcón GS, Anaya JM, Bae SC, Kim D, Lee HS, Criswell LA, Freedman BI, Gilkeson GS, Guthridge JM, Jacob CO, James JA, Kamen DL, Merrill JT, Sivils KM, Niewold TB, Petri MA, Ramsey-Goldman R, Reveille JD, Scofield RH, Stevens AM, Vilá LM, Vyse TJ, Kaufman KM, Harley JB, Langefeld CD, Gaffney PM, Brown EE, Edberg JC, Kimberly RP, Ulgiati D, Tsao BP, Boackle SA.

Ann Rheum Dis. 2016 Jan;75(1):242-52. doi: 10.1136/annrheumdis-2014-205584. Epub 2014 Sep 1.

38.

Mitochondrial DNA damage is associated with damage accrual and disease duration in patients with systemic lupus erythematosus.

López-López L, Nieves-Plaza M, Castro Mdel R, Font YM, Torres-Ramos CA, Vilá LM, Ayala-Peña S.

Lupus. 2014 Oct;23(11):1133-41. doi: 10.1177/0961203314537697. Epub 2014 Jun 4.

39.

Osteoporosis knowledge in patients with a first fragility fracture in Puerto Rico.

Díaz-Correa LM, Ramírez-García LM, Castro-Santana LE, Vilá LM.

Bol Asoc Med P R. 2014;106(1):6-10.

PMID:
24791357
40.

Fcγ receptor IIIa single-nucleotide polymorphisms and haplotypes affect human IgG binding and are associated with lupus nephritis in African Americans.

Dong C, Ptacek TS, Redden DT, Zhang K, Brown EE, Edberg JC, McGwin G Jr, Alarcón GS, Ramsey-Goldman R, Reveille JD, Vilá LM, Petri M, Qin A, Wu J, Kimberly RP.

Arthritis Rheumatol. 2014 May;66(5):1291-9. doi: 10.1002/art.38337.

41.

Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription.

Guthridge JM, Lu R, Sun H, Sun C, Wiley GB, Dominguez N, Macwana SR, Lessard CJ, Kim-Howard X, Cobb BL, Kaufman KM, Kelly JA, Langefeld CD, Adler AJ, Harley IT, Merrill JT, Gilkeson GS, Kamen DL, Niewold TB, Brown EE, Edberg JC, Petri MA, Ramsey-Goldman R, Reveille JD, Vilá LM, Kimberly RP, Freedman BI, Stevens AM, Boackle SA, Criswell LA, Vyse TJ, Behrens TW, Jacob CO, Alarcón-Riquelme ME, Sivils KL, Choi J, Joo YB, Bang SY, Lee HS, Bae SC, Shen N, Qian X, Tsao BP, Scofield RH, Harley JB, Webb CF, Wakeland EK, James JA, Nath SK, Graham RR, Gaffney PM.

Am J Hum Genet. 2014 Apr 3;94(4):586-98. doi: 10.1016/j.ajhg.2014.03.008.

42.

Association of the use of statins with disease activity and functional status in Puerto Ricans with rheumatoid arthritis.

Villafrádez-Díaz M, Santiago-Casas Y, Nieves-Plaza M, Morales M, Rodríguez V, Ríos G, Martínez D, Vilá LM.

P R Health Sci J. 2014 Mar;33(1):3-8.

43.

A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus.

Kaiser R, Tang LF, Taylor KE, Sterba K, Nititham J, Brown EE, Edberg JC, McGwin G Jr, Alarcón GS, Ramsey-Goldman R, Reveille JD, Vilá LM, Petri M, Rauch J, Miller E, Mesznik K, Kwok PY, Kimberly RP, Salmon JE, Criswell LA.

Arthritis Rheumatol. 2014 Jul;66(7):1882-7. doi: 10.1002/art.38520.

44.

Factors associated with regional rheumatic pain disorders in a population of Puerto Ricans with diabetes mellitus.

Font YM, Castro-Santana LE, Nieves-Plaza M, Maldonado M, Mayor AM, Vilá LM.

Clin Rheumatol. 2014 Jul;33(7):995-1000. doi: 10.1007/s10067-013-2474-1. Epub 2014 Feb 13.

45.

Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort.

Willis R, Seif AM, McGwin G Jr, Martinez-Martinez LA, González EB, Doan E, Dang N, Papalardo E, Liu J, Vilá LM, Reveille JD, Alarcón GS, Pierangeli SS.

Clin Exp Rheumatol. 2014 Mar-Apr;32(2):162-7. Epub 2014 Jan 24.

PMID:
24480124
46.

Infective endocarditis initially presenting with a dermatomyositis-like syndrome.

Ojeda J, López-López L, González A, Vilá LM.

BMJ Case Rep. 2014 Jan 10;2014. pii: bcr2013200865. doi: 10.1136/bcr-2013-200865.

47.

Lymphocyte sensitivity assay as a marker for glucocorticoid resistance in lupus: report of two sisters with systemic lupus erythematosus.

Fajardo-Hermosillo LD, Rodríguez-Navedo Y, Nadal AJ, Vilá LM.

Lupus. 2014;23(1):88-92. doi: 10.1177/0961203313513507. Epub 2013 Nov 27.

PMID:
24285097
48.

Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression.

Sakurai D, Zhao J, Deng Y, Kelly JA, Brown EE, Harley JB, Bae SC, Alarcόn-Riquelme ME; BIOLUPUS and GENLES networks, Edberg JC, Kimberly RP, Ramsey-Goldman R, Petri MA, Reveille JD, Vilá LM, Alarcón GS, Kaufman KM, Vyse TJ, Jacob CO, Gaffney PM, Sivils KM, James JA, Kamen DL, Gilkeson GS, Niewold TB, Merrill JT, Scofield RH, Criswell LA, Stevens AM, Boackle SA, Kim JH, Choi J, Pons-Estel BA; Argentine Collaborative Group, Freedman BI, Anaya JM, Martin J, Yu CY, Chang DM, Song YW, Langefeld CD, Chen W, Grossman JM, Cantor RM, Hahn BH, Tsao BP.

PLoS Genet. 2013;9(10):e1003870. doi: 10.1371/journal.pgen.1003870. Epub 2013 Oct 10.

49.

Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome.

Murthy V, Willis R, Romay-Penabad Z, Ruiz-Limón P, Martínez-Martínez LA, Jatwani S, Jajoria P, Seif A, Alarcón GS, Papalardo E, Liu J, Vilá LM, McGwin G Jr, McNearney TA, Maganti R, Sunkureddi P, Parekh T, Tarantino M, Akhter E, Fang H, Gonzalez EB, Binder WR, Norman GL, Shums Z, Teodorescu M, Reveille JD, Petri M, Pierangeli SS.

Arthritis Rheum. 2013 Dec;65(12):3186-93. doi: 10.1002/art.38131.

50.

ABIN1 dysfunction as a genetic basis for lupus nephritis.

Caster DJ, Korte EA, Nanda SK, McLeish KR, Oliver RK, G'sell RT, Sheehan RM, Freeman DW, Coventry SC, Kelly JA, Guthridge JM, James JA, Sivils KL, Alarcon-Riquelme ME, Scofield RH, Adrianto I, Gaffney PM, Stevens AM, Freedman BI, Langefeld CD, Tsao BP, Pons-Estel BA, Jacob CO, Kamen DL, Gilkeson GS, Brown EE, Alarcon GS, Edberg JC, Kimberly RP, Martin J, Merrill JT, Harley JB, Kaufman KM, Reveille JD, Anaya JM, Criswell LA, Vila LM, Petri M, Ramsey-Goldman R, Bae SC, Boackle SA, Vyse TJ, Niewold TB, Cohen P, Powell DW.

J Am Soc Nephrol. 2013 Nov;24(11):1743-54. doi: 10.1681/ASN.2013020148. Epub 2013 Aug 22.

Supplemental Content

Support Center